Sign In
Buy SBMFF
$0.637
+0 (+0%)
At Close: Jul 13, 2026
Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs
12:52am, Wednesday, 08'th Jul 2026
Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China unit had secured rights to market two respiratory drugs from British company GSK in mainland China.
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
11:44pm, Tuesday, 07'th Jul 2026
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion
06:48pm, Tuesday, 07'th Jul 2026
Hong Kong-listed Sino Biopharmaceutical said on Wednesday it has granted AstraZeneca the rights to develop a drug designed to treat chronic respiratory diseases outside China for total pay
Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
09:49pm, Tuesday, 06'th Feb 2024
Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the compan
China's health-care sector may be next to face regulatory crackdown, says economist
03:49am, Friday, 24'th Sep 2021
Dan Wang of Hang Seng Bank (China) says China's public health-care system is still expensive for ordinary people. The country's regulatory reform will be nationwide and have an international impact, s
Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea
07:31pm, Sunday, 07'th Mar 2021
Cancer killed far more people around the world than Covid-19 in 2020
